Royalty Pharma plc - SIC # 6794 - PATENT OWNERS AND LESSORS

Ticker Exchange SIC # Website Latest Ticker
RPRX Nasdaq 6794 https://www.royaltypharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Royalty Pharma plc

Royalty Pharma Raises Full Year 2023 Guidance - Mar 15th, 2023 12:00 pm
Optimism around Royalty Pharma (NASDAQ:RPRX) delivering new earnings growth may be shrinking as stock declines 3.5% this past week - Mar 8th, 2023 10:16 am
Royalty Pharma Appoints Ashwin Pai as Executive Vice President, Investments - Mar 1st, 2023 1:15 pm
Royalty Pharma Reports Q4 and Full Year 2022 Results - Feb 15th, 2023 12:00 pm
Royalty Pharma to Present at Upcoming Investor Conferences - Feb 9th, 2023 9:15 pm
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To $0.20 - Feb 3rd, 2023 2:19 pm
Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023 - Jan 18th, 2023 1:25 pm
Royalty Pharma's (NASDAQ:RPRX) Shareholders Will Receive A Bigger Dividend Than Last Year - Jan 12th, 2023 10:01 am
Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference - Jan 9th, 2023 2:25 pm
Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness - Jan 9th, 2023 2:15 pm
Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness - Jan 9th, 2023 2:05 pm
Royalty Pharma Announces Dividend Increase - Jan 9th, 2023 1:30 pm
In the wake of Royalty Pharma plc's (NASDAQ:RPRX) latest US$631m market cap drop, institutional owners may be forced to take severe actions - Jan 9th, 2023 11:35 am
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9 - Jan 4th, 2023 9:15 pm
Royalty Pharma Announces Expansion of Senior Leadership Team - Dec 15th, 2022 1:15 pm
Is Royalty Pharma plc (NASDAQ:RPRX) Trading At A 50% Discount? - Dec 8th, 2022 10:23 am
Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference - Nov 28th, 2022 9:26 pm
Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones - Nov 9th, 2022 1:49 pm
Arrowhead Sells Royalty Interest in Olpasiran to Royalty Pharma for $250 Million and Future Milestones - Nov 9th, 2022 1:10 pm
Royalty Pharma Reports Third Quarter 2022 Results - Nov 8th, 2022 12:00 pm